With over a decade of experience, thousands of lives changed, and a long-standing record of delivering programmes used by the NHS, we believe we're the UK's most trusted weight-loss programme
Retatrutide is a new drug for obesity that is currently being developed by Eli Lilly
For example, GLP-1RAs were proven in the clinic to slow the disease progression of Alzheimers disease and Parkinsons disease, attributed in part to their anti-inflammatory and neuroprotective properties [16, 18,19,20,21,22]
Both are made by Novo Nordisk, which may contribute to the confusion
If price is the reason a patient is considering gray-market access, manufacturer assistance programs and direct-to-consumer pharmacy options for the existing approved drugs are usually a better starting place to discuss with a physician
These symptoms can have several causes, but they should not be watched casually